These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 29773661)

  • 21. Peritoneal Metastases from Malignant Mesothelioma.
    Li CY; Alexander HR
    Surg Oncol Clin N Am; 2018 Jul; 27(3):539-549. PubMed ID: 29935688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peritonectomy combined with intraperitoneal chemohyperthermia in abdominal cancer with peritoneal carcinomatosis: phase I-II study.
    Gilly FN; Beaujard A; Glehen O; Grandclement E; Caillot JL; Francois Y; Sadeghi-Looyeh B; Gueugniaud PY; Garbit F; Benoit M; Bienvenu J; Vignal J
    Anticancer Res; 1999; 19(3B):2317-21. PubMed ID: 10472351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon γ improves the vaccination potential of oncolytic parvovirus H-1PV for the treatment of peritoneal carcinomatosis in pancreatic cancer.
    Grekova SP; Aprahamian M; Daeffler L; Leuchs B; Angelova A; Giese T; Galabov A; Heller A; Giese NA; Rommelaere J; Raykov Z
    Cancer Biol Ther; 2011 Nov; 12(10):888-95. PubMed ID: 22024742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conversion to Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma After Bidirectional Chemotherapy.
    Le Roy F; Gelli M; Hollebecque A; Honoré C; Boige V; Dartigues P; Benhaim L; Malka D; Ducreux M; Elias D; Goéré D
    Ann Surg Oncol; 2017 Nov; 24(12):3640-3646. PubMed ID: 28849389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vesicular stomatitis virus is a potent agent for the treatment of malignant ascites.
    Zhou Y; Wen F; Zhang P; Tang R; Li Q
    Oncol Rep; 2016 Mar; 35(3):1573-81. PubMed ID: 26707610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiological predictors of complete cytoreduction in 59 patients with peritoneal mesothelioma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a UK referral centre.
    Chandramohan A; Thrower A; Shah N; Mohamed F
    Br J Radiol; 2017 Nov; 90(1079):20170361. PubMed ID: 28830230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of the Na/I symporter as a reporter gene to visualize oncolytic adenovirus propagation in peritoneal tumours.
    Merron A; Baril P; Martin-Duque P; de la Vieja A; Tran L; Briat A; Harrington KJ; McNeish IA; Vassaux G
    Eur J Nucl Med Mol Imaging; 2010 Jul; 37(7):1377-85. PubMed ID: 20140612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new recombinant vaccinia with targeted deletion of three viral genes: its safety and efficacy as an oncolytic virus.
    Yang S; Guo ZS; O'Malley ME; Yin X; Zeh HJ; Bartlett DL
    Gene Ther; 2007 Apr; 14(8):638-47. PubMed ID: 17268533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene therapy using adenovirus against malignant mesothelioma.
    Gotoh A; Kanno T; Nagaya H; Nakano T; Tabata C; Fukuoka K; Tagawa M; Nishizaki T
    Anticancer Res; 2012 Sep; 32(9):3743-7. PubMed ID: 22993314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase I study of intraperitoneal recombinant human interleukin 12 in patients with Müllerian carcinoma, gastrointestinal primary malignancies, and mesothelioma.
    Lenzi R; Rosenblum M; Verschraegen C; Kudelka AP; Kavanagh JJ; Hicks ME; Lang EA; Nash MA; Levy LB; Garcia ME; Platsoucas CD; Abbruzzese JL; Freedman RS
    Clin Cancer Res; 2002 Dec; 8(12):3686-95. PubMed ID: 12473577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase 1 Study of Intravenous Oncolytic Poxvirus (vvDD) in Patients With Advanced Solid Cancers.
    Downs-Canner S; Guo ZS; Ravindranathan R; Breitbach CJ; O'Malley ME; Jones HL; Moon A; McCart JA; Shuai Y; Zeh HJ; Bartlett DL
    Mol Ther; 2016 Aug; 24(8):1492-501. PubMed ID: 27203445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune Effects of M51R Vesicular Stomatitis Virus Treatment of Carcinomatosis From Colon Cancer.
    Day GL; Bryan ML; Northrup SA; Lyles DS; Westcott MM; Stewart JH
    J Surg Res; 2020 Jan; 245():127-135. PubMed ID: 31415934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrence of Optimally Treated Malignant Peritoneal Mesothelioma with Cytoreduction and Heated Intraperitoneal Chemotherapy.
    Heller DR; Chiuzan C; Taub RN; Leinwand JC; Greene AM; Bates GE; Chabot JA; Kluger MD
    Ann Surg Oncol; 2017 Dec; 24(13):3818-3824. PubMed ID: 29027138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary Peritoneal Mesothelioma Resulting in Small Bowel Obstruction: A Case Report and Review of Literature.
    Frontario SC; Loveitt A; Goldenberg-Sandau A; Liu J; Roy D; Cohen LW
    Am J Case Rep; 2015 Jul; 16():496-500. PubMed ID: 26222965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genomic copy number alterations in 33 malignant peritoneal mesothelioma analyzed by comparative genomic hybridization array.
    Chirac P; Maillet D; Leprêtre F; Isaac S; Glehen O; Figeac M; Villeneuve L; Péron J; Gibson F; Galateau-Sallé F; Gilly FN; Brevet M
    Hum Pathol; 2016 Sep; 55():72-82. PubMed ID: 27184482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Telomerase-specific oncolytic adenovirus expressing TRAIL suppresses peritoneal dissemination of gastric cancer.
    Zhou W; Dai S; Zhu H; Song Z; Cai Y; Lee JB; Li Z; Hu X; Fang B; He C; Huang X
    Gene Ther; 2017 Apr; 24(4):199-207. PubMed ID: 28075429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. REO-001: A phase I trial of percutaneous intralesional administration of reovirus type 3 dearing (Reolysin®) in patients with advanced solid tumors.
    Morris DG; Feng X; DiFrancesco LM; Fonseca K; Forsyth PA; Paterson AH; Coffey MC; Thompson B
    Invest New Drugs; 2013 Jun; 31(3):696-706. PubMed ID: 22886613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inducible gene expression in tumors colonized by modified oncolytic vaccinia virus strains.
    Stritzker J; Huppertz S; Zhang Q; Geissinger U; Härtl B; Gentschev I; Szalay AA
    J Virol; 2014 Oct; 88(19):11556-67. PubMed ID: 25056902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preventing recurrence of diffuse malignant peritoneal mesothelioma.
    Leinwand JC; Chabot JA; Kluger MD
    Expert Rev Anticancer Ther; 2016 Sep; 16(9):989-95. PubMed ID: 27486718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of intravenous versus intraperitoneal administration of oncolytic herpes simplex virus 1 for peritoneal carcinomatosis in mice.
    Kulu Y; Dorfman JD; Kuruppu D; Fuchs BC; Goodwin JM; Fujii T; Kuroda T; Lanuti M; Tanabe KK
    Cancer Gene Ther; 2009 Apr; 16(4):291-7. PubMed ID: 18989355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.